TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX)

CUSIP: 88032L605

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
18,453,093
Total 13F shares
6,948,962
Share change
+2,212,928
Total reported value
$84,695,343
Price per share
$12.19
Number of holders
47
Value change
+$29,084,194
Number of buys
29
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 88032L605?
CUSIP 88032L605 identifies TENX - TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q4 2025

As of 31 Dec 2025, TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,948,962 shares. The largest 10 holders included Ikarian Capital, LLC, MORGAN STANLEY, PERCEPTIVE ADVISORS LLC, Siren, L.L.C., Point72 Asset Management, L.P., RTW INVESTMENTS, LP, BOOTHBAY FUND MANAGEMENT, LLC, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, and MARSHALL WACE, LLP. This page lists 47 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.